Literature DB >> 11891618

Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus.

Stephanie M Fullerton1, Angelika Bartoszewicz, Gustavo Ybazeta, Yukio Horikawa, Graeme I Bell, Kenneth K Kidd, Nancy J Cox, Richard R Hudson, Anna Di Rienzo.   

Abstract

Recently, a positional cloning study proposed that haplotypes at the calpain-10 locus (CAPN10) are associated with increased risk of type 2 diabetes, or non-insulin-dependent diabetes mellitus, in Mexican Americans, Finns, and Germans. To inform the interpretation of the original mapping results and to look for evidence for the action of natural selection on CAPN10, we undertook a population-based genotyping survey of the candidate susceptibility variants. First, we genotyped sites 43, 19, and 63 (the haplotype-defining variants previously proposed) and four closely linked SNPs, in 561 individuals from 11 populations from five continents, and we examined the linkage disequilibrium among them. We then examined the ancestral state of these sites by sequencing orthologous portions of CAPN10 in chimpanzee and orangutan (the identity of sites 43 and 19 was further investigated in a limited sample of other great apes and Old World and New World monkeys). Our survey suggests larger-than-expected differences in the distribution of CAPN10 susceptibility variants between African and non-African populations, with common, derived haplotypes in European and Asian samples (including one of two proposed risk haplotypes) being rare or absent in African samples. These results suggest a history of positive natural selection at the locus, resulting in significant geographic differences in polymorphism frequencies. The relationship of these differences to disease risk is discussed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891618      PMCID: PMC447588          DOI: 10.1086/339930

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  28 in total

1.  The accuracy of statistical methods for estimation of haplotype frequencies: an example from the CD4 locus.

Authors:  S A Tishkoff; A J Pakstis; G Ruano; K K Kidd
Journal:  Am J Hum Genet       Date:  2000-06-19       Impact factor: 11.025

2.  Absence of association of type 2 diabetes with CAPN10 and PC-1 polymorphisms in Oji-Cree.

Authors:  R A Hegele; S B Harris; B Zinman; A J Hanley; H Cao
Journal:  Diabetes Care       Date:  2001-08       Impact factor: 19.112

3.  Gene conversion and different population histories may explain the contrast between polymorphism and linkage disequilibrium levels.

Authors:  L Frisse; R R Hudson; A Bartoszewicz; J D Wall; J Donfack; A Di Rienzo
Journal:  Am J Hum Genet       Date:  2001-08-29       Impact factor: 11.025

4.  Study of an additional 58 DNA markers in five human populations from four continents.

Authors:  A M Bowcock; J M Hebert; J L Mountain; J R Kidd; J Rogers; K K Kidd; L L Cavalli-Sforza
Journal:  Gene Geogr       Date:  1991-12

5.  SNP43 of CAPN10 and the risk of type 2 Diabetes in African-Americans: the Atherosclerosis Risk in Communities Study.

Authors:  Michael J Garant; W H Linda Kao; Frederick Brancati; Josef Coresh; Tejal M Rami; Craig L Hanis; Eric Boerwinkle; Alan R Shuldiner
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

6.  Characterization and expression of calpain 10. A novel ubiquitous calpain with nuclear localization.

Authors:  H Ma; C Fukiage; Y H Kim; M K Duncan; N A Reed; M Shih; M Azuma; T R Shearer
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

7.  Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom.

Authors:  J C Evans; T M Frayling; P G Cassell; P J Saker; G A Hitman; M Walker; J C Levy; S O'Rahilly; P V Rao; A J Bennett; E C Jones; S Menzel; P Prestwich; N Simecek; M Wishart; R Dhillon; C Fletcher; A Millward; A Demaine; T Wilkin; Y Horikawa; N J Cox; G I Bell; S Ellard; M I McCarthy; A T Hattersley
Journal:  Am J Hum Genet       Date:  2001-07-31       Impact factor: 11.025

8.  A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance.

Authors:  L J Baier; P A Permana; X Yang; R E Pratley; R L Hanson; G Q Shen; D Mott; W C Knowler; N J Cox; Y Horikawa; N Oda; G I Bell; C Bogardus
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus.

Authors:  Y Horikawa; N Oda; N J Cox; X Li; M Orho-Melander; M Hara; Y Hinokio; T H Lindner; H Mashima; P E Schwarz; L del Bosque-Plata; Y Horikawa; Y Oda; I Yoshiuchi; S Colilla; K S Polonsky; S Wei; P Concannon; N Iwasaki; J Schulze; L J Baier; C Bogardus; L Groop; E Boerwinkle; C L Hanis; G I Bell
Journal:  Nat Genet       Date:  2000-10       Impact factor: 38.330

10.  Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence of association.

Authors:  H J Tsai; G Sun; D E Weeks; R Kaushal; M Wolujewicz; S T McGarvey; J Tufa; S Viali; R Deka
Journal:  Am J Hum Genet       Date:  2001-11-05       Impact factor: 11.025

View more
  41 in total

1.  Interrogating a high-density SNP map for signatures of natural selection.

Authors:  Joshua M Akey; Ge Zhang; Kun Zhang; Li Jin; Mark D Shriver
Journal:  Genome Res       Date:  2002-12       Impact factor: 9.043

2.  Variable continental distribution of polymorphisms in the coding regions of DNA-repair genes.

Authors:  Géraldine Mathonnet; Damian Labuda; Caroline Meloche; Tina Wambach; Maja Krajinovic; Daniel Sinnett
Journal:  J Hum Genet       Date:  2003-11-19       Impact factor: 3.172

3.  Confirmation of linkage to chromosome 1q for peak vertebral bone mineral density in premenopausal white women.

Authors:  Michael J Econs; Daniel L Koller; Siu L Hui; Tonya Fishburn; P Michael Conneally; C Conrad Johnston; Munro Peacock; Tatiana M Foroud
Journal:  Am J Hum Genet       Date:  2004-01-16       Impact factor: 11.025

4.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

5.  Human-specific derived alleles of CD33 and other genes protect against postreproductive cognitive decline.

Authors:  Flavio Schwarz; Stevan A Springer; Tasha K Altheide; Nissi M Varki; Pascal Gagneux; Ajit Varki
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-30       Impact factor: 11.205

6.  Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.

Authors:  J Pihlajamäki; U Salmenniemi; M Vänttinen; E Ruotsalainen; J Kuusisto; I Vauhkonen; S Kainulainen; M C Y Ng; N J Cox; G I Bell; M Laakso
Journal:  Diabetologia       Date:  2006-05-12       Impact factor: 10.122

7.  Rapid evolution, genetic variations, and functional association of the human spermatogenesis-related gene NYD-SP12.

Authors:  Qü Zhang; Feng Zhang; Xiao-Hua Chen; Yin-Qiu Wang; Wei-Qi Wang; Alice A Lin; Luca L Cavalli-Sforza; Li Jin; Ran Huo; Jia-Hao Sha; Zheng Li; Bing Su
Journal:  J Mol Evol       Date:  2007-07-30       Impact factor: 2.395

8.  Genetic variation and population structure of interleukin genes among seven ethnic populations from Karnataka, India.

Authors:  Srilakshmi M Raj; Diddahally R Govindaraju; Ranajit Chakraborty
Journal:  J Genet       Date:  2007-12       Impact factor: 1.166

Review 9.  Calpain 10 and genetics of type 2 diabetes.

Authors:  Nancy J Cox
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 10.  Finding the Genomic Basis of Local Adaptation: Pitfalls, Practical Solutions, and Future Directions.

Authors:  Sean Hoban; Joanna L Kelley; Katie E Lotterhos; Michael F Antolin; Gideon Bradburd; David B Lowry; Mary L Poss; Laura K Reed; Andrew Storfer; Michael C Whitlock
Journal:  Am Nat       Date:  2016-08-15       Impact factor: 3.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.